$26.20
0.61% day before yesterday
NYSE, Dec 20, 10:19 pm CET
ISIN
US4330001060
Symbol
HIMS

Hims & Hers Health Inc. Target price 2024 - Analyst rating & recommendation

Hims & Hers Health Inc. Classifications & Recommendation:

Buy
47%
Hold
47%
Sell
7%

Hims & Hers Health Inc. Price Target

Target Price $27.86
Price $26.20
Potential
Number of Estimates 14
14 Analysts have issued a price target Hims & Hers Health Inc. 2025 . The average Hims & Hers Health Inc. target price is $27.86. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 15 analysts: 7 Analysts recommend Hims & Hers Health Inc. to buy, 7 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Hims & Hers Health Inc. stock has an average upside potential 2025 of . Most analysts recommend the Hims & Hers Health Inc. stock at Buy or hold.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion $ 0.87 1.46
65.49% 67.37%
EBITDA Margin -2.75% 12.14%
76.28% 542.01%
Net Margin -2.75% 7.99%
79.23% 390.79%

15 Analysts have issued a sales forecast Hims & Hers Health Inc. 2024 . The average Hims & Hers Health Inc. sales estimate is

$1.5b
Unlock
. This is
17.51% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.5b 18.80%
Unlock
, the lowest is
$1.4b 11.11%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $872m 65.49%
2024
$1.5b 67.37%
Unlock
2025
$2.0b 38.31%
Unlock
2026
$2.3b 16.27%
Unlock
2027
$2.7b 15.09%
Unlock
2028
$2.8b 4.92%
Unlock

14 Analysts have issued an Hims & Hers Health Inc. EBITDA forecast 2024. The average Hims & Hers Health Inc. EBITDA estimate is

$177m
Unlock
. This is
252.79% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$181m 260.09%
Unlock
, the lowest is
$175m 249.15%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-24.0m 60.74%
2024
$177m 839.61%
Unlock
2025
$263m 48.59%
Unlock
2026
$323m 22.70%
Unlock
2027
$382m 18.32%
Unlock
2028
$439m 14.96%
Unlock

EBITDA Margin

2023 -2.75% 76.28%
2024
12.14% 542.01%
Unlock
2025
13.04% 7.41%
Unlock
2026
13.76% 5.52%
Unlock
2027
14.15% 2.83%
Unlock
2028
15.50% 9.54%
Unlock

12 Hims & Hers Health Inc. Analysts have issued a net profit forecast 2024. The average Hims & Hers Health Inc. net profit estimate is

$117m
Unlock
. This is
24.56% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$137m 46.52%
Unlock
, the lowest is
$98.0m 4.65%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-24.0m 65.63%
2024
$117m 586.93%
Unlock
2025
$110m 5.81%
Unlock
2026
$150m 36.95%
Unlock
2027
$185m 22.72%
Unlock
2028
$178m 3.88%
Unlock

Net Margin

2023 -2.75% 79.23%
2024
7.99% 390.79%
Unlock
2025
5.44% 31.91%
Unlock
2026
6.41% 17.83%
Unlock
2027
6.84% 6.71%
Unlock
2028
6.26% 8.48%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -0.11 0.54
65.63% 590.91%
P/E 48.92
EV/Sales 3.76

12 Analysts have issued a Hims & Hers Health Inc. forecast for earnings per share. The average Hims & Hers Health Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$0.54
Unlock
. This is
25.58% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$0.63 46.51%
Unlock
, the lowest is
$0.45 4.65%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.11 65.63%
2024
$0.54 590.91%
Unlock
2025
$0.50 7.41%
Unlock
2026
$0.69 38.00%
Unlock
2027
$0.85 23.19%
Unlock
2028
$0.82 3.53%
Unlock

P/E ratio

Current 60.61 223.29%
2024
48.92 19.29%
Unlock
2025
51.93 6.15%
Unlock
2026
37.92 26.98%
Unlock
2027
30.90 18.51%
Unlock
2028
32.15 4.05%
Unlock

Based on analysts' sales estimates for 2024, the Hims & Hers Health Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.41 120.50%
2024
3.76 14.84%
Unlock
2025
2.72 27.70%
Unlock
2026
2.34 13.99%
Unlock
2027
2.03 13.11%
Unlock
2028
1.93 4.69%
Unlock

P/S ratio

Current 4.61 103.92%
2024
3.92 14.90%
Unlock
2025
2.84 27.70%
Unlock
2026
2.44 14.00%
Unlock
2027
2.12 13.10%
Unlock
2028
2.02 4.69%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today